not used title
not used title
The PhRMA Foundation is undertaking the largest expansion in its 60-year history, with This is more than a 250% increase than what the Foundation has committed to in the past 3 years.
Why it matters: As global competition for biopharmaceutical leadership intensifies, maintaining America’s edge starts with investing in the scientists who will drive the next generation of discoveries. Supporting talented researchers early in their careers helps ensure the U.S. remains at the forefront of developing new medicines for patients.
deeper: Leading biopharmaceutical companies have already pledged more than $16 million to the initiative, reflecting the industry’s commitment to fostering the next generation of scientific leaders. This means the Foundation is halfway to the resources that it needs for the three-year expansion.
The expansion will provide additional fellowship opportunities for predoctoral students and postdoctoral trainees at U.S. universities conducting investigator-driven research in drug discovery, drug delivery and translational medicine.
While the Foundation has traditionally funded 30 to 50 researchers each year, this initiative aims to support 500 early-career researchers over the next three years.
The bottom line: America’s biopharmaceutical leadership depends on a strong pipeline of scientific talent. By investing in early-career researchers today, the PhRMA Foundation and the biopharmaceutical industry are helping build the workforce that will drive tomorrow’s scientific breakthroughs and advance new medicines for patients.
Learn more about the PhRMA Foundation and its commitment to catalyzing the careers of promising researchers.
Amy Miller
Amy M. Miller, PhD, is President of the PhRMA Foundation, an independent nonprofit that fosters biopharmaceutical innovation by investing in foundational research advancing drug discovery, drug delivery, translational medicine, and value-driven health care. Dr. Miller is a seasoned nonprofit leader with a distinguished career in advancing biomedical research and health care policy. Before joining the PhRMA Foundation, she served as President and CEO of the Society for Women’s Health Research (SWHR), where she championed women's health issues through science, policy and education. Prior to that, she was Executive Vice President of the Personalized Medicine Coalition (PMC), a 200+ member advocacy coalition dedicated to advancing personalized medicine across the health care ecosystem. Before entering nonprofit management, Dr. Miller worked in government, both within the National Institutes of Health and the U.S. Senate. She holds a bachelor’s degree from the University of New Orleans and a doctoral degree from the University of Connecticut.
ICYMI: Huntsville’s biopharma ecosystem is poised for growth
November 2, 2026
PhRMA to USTR: Use trade policy to defend American innovation
November 2, 2026
The $1.74 trillion sector powering America’s economy
October 29, 2026
Houston’s clinical research ecosystem is building momentum
October 21, 2026
Recognizing the transformative impact of intellectual property
October 13, 2026
ICYMI: Pennsylvania shows what biopharmaceutical innovation can deliver
September 21, 2026
How 250 years of smart policy built America's biopharmaceutical edge
July 2, 2026
Staffing up: Building the future biopharma workforce to keep America in the lead
June 29, 2026
MFN price controls threaten American jobs and the U.S. economy
May 28, 2026
CNBC: Maintaining America’s lead in medical innovation
April 21, 2026
Policymakers shouldn’t double down on the IRA’s flaws with MFN
March 30, 2026
How AI is transforming the drug innovation lifecycle
March 19, 2026
Leadership in biopharmaceutical R&D provides U.S. patients the greatest access to innovative medicines
March 11, 2026
Harmful U.S. policies will help drive China’s global leadership in biopharmaceutical innovation
March 4, 2026
Americans believe U.S. pharma leadership needs to be protected
February 26, 2026
MFN undermines U.S. biopharmaceutical innovation
February 25, 2026
CMS puts patients and innovation at risk with MFN
February 24, 2026
America Cures: Championing U.S. leadership in medical innovation
February 18, 2026
PhRMA Forum 2026 highlights the importance of fostering the next era of American leadership
February 18, 2026
Middlemen mark up drug prices and keep discounts meant for you
November 10, 2025
Celebrating STEM Day: Investing in America’s innovators
November 8, 2025
Manufacturing U.S. jobs and breakthroughs
October 6, 2025
Historic biopharmaceutical investments: A prescription for America’s future
September 29, 2025
PhRMA Foundation celebrates 60 years of investing in future scientific leaders
June 11, 2025
Strong Trade Policies Protect American Workers and Biopharmaceutical Innovation
March 12, 2025
New research: Industry sponsored clinical trials contribute billions to state economies
March 6, 2025
Industry-backed STEM programs have supported 111 million students and nearly 183,000 teachers
August 1, 2024
Biopharmaceutical industry supports jobs and drives economic growth across the United States
May 16, 2024
Biden Administration’s Indo Pacific trade dialogue is a missed opportunity to bolster American exports, innovation
November 29, 2023
The Biden Administration has failed to advance an inclusive, worker-centered trade agenda
September 5, 2023
Four ways that America’s biopharmaceutical industry supports jobs and fuels economic growth
May 18, 2023
3 things about the PhRMA Foundation
May 15, 2023
U.S. biopharmaceutical exports support jobs, innovation
March 20, 2023
ICYMI: New research builds upon growing body of evidence on value of COVID-19 treatments and vaccines
August 16, 2022
The Senate’s latest price setting proposal will undermine U.S. economic growth
August 3, 2022
ICYMI: A patient, physician, biotech investor and industry leaders warn about the dangers of government price setting bill
July 29, 2022
PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021
July 18, 2022
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US
July 14, 2022
COVID-19 vaccines and treatments helped save millions of lives and billions in health care costs
July 7, 2022
Biopharmaceutical industry drives economic growth in all 50 states
March 14, 2022
PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020
July 22, 2021
Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery
July 2, 2021
Beyond output and employment: The impact of America’s biopharmaceutical industry
February 11, 2021
Preserving U.S. innovation worldwide is more important than ever
January 29, 2021
American biopharmaceutical manufacturing: Fueling economic growth now and for years to come
December 21, 2020
Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions
October 2, 2020
America’s global leadership in biopharmaceutical manufacturing
June 4, 2020
New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output
February 12, 2020
What you need to know about H.R. 3
December 12, 2019
New poll: 76% of voters concerned Speaker Pelosi’s plan would result in fewer new medicines
December 5, 2019
IP Explained: By the Numbers: How reliable IP protections promote a strong U.S. economy
November 4, 2019
What they are saying: Negative impact of Pelosi’s plan on biopharmaceutical innovation
October 31, 2019
Pelosi’s radical plan leaves lung cancer patients behind
October 23, 2019
Event tomorrow: Maintaining America’s leadership in access and innovation
October 16, 2019
Pelosi’s radical plan would leave Alzheimer’s patients behind
October 16, 2019
What they are saying: Broad opposition to Pelosi’s radical drug pricing plan
October 10, 2019
On Manufacturing Day, a closer look at the biopharmaceutical sector’s contributions
October 4, 2019
By the Numbers: Pelosi’s radical plan puts America’s economy and jobs at risk
September 26, 2019
World Trade Month: How we can expand world-class pro-innovation standards
May 22, 2019
New Report: Advanced manufacturing powering innovative biopharmaceuticals
May 10, 2019
Clinical trials impact state economies
May 3, 2019
Biopharmaceutical venture capital is spurring innovation and economic growth
February 11, 2019
Safe and effective prescribing: A new and important initiative from the PhRMA Foundation
September 26, 2018
PhRMA member companies R&D investments hit record high in 2017 - $71.4 billion
August 9, 2018
Researchers bring focus on science and medicine to California’s capital city
May 29, 2018
To continue to drive the innovation economy and exports, American biopharmaceutical sector depends on fair trade agreements
May 10, 2018
New Report: America's biopharmaceutical industry supports 4.7 million jobs
March 1, 2018
PhRMA Foundation recognizes inaugural Challenge Award recipients
October 6, 2017
New PhRMA resources chock full of biopharma industry facts
July 20, 2017
New medicines are part of the solution to hold down future health care costs
June 28, 2017
American Leadership
Economic Impact
PhRMA Foundation
PhRMA Foundation makes unprecedented investment in America’s future scientific workforce
October 5, 2026